Add to myBIO Planner Notes

We’ve heard time and again that the drug development process is inefficient. Today, new technology and digital health platforms deploy advanced computational techniques and new data methodologies across the R&D continuum. In the drug discovery stage, new platforms are allowing drug hunters to identify the best therapeutic nodes of disease and target new domains, such as RNA-targeting with small molecules. Even in early R&D, technologies can incorporate patient data to increase the confidence in the human relevance of drug targets and candidates, including new techniques such as Organs-on-Chips technology that have human cells on chips.

Ability Level: All

Session ID: 21256